Physician profile
Marina Behrad
NPI 1821267873
$1,516.80
in general payments reported to CMS, 2019-2025
18 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $40.86 · 2022: $167 · 2023: $281 · 2024: $505 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,056.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,055.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $252.13 | 2022-2025 | Freestyle Libre 3, Proclaim |
| Glaxosmithkline, LLC. | $201.43 | 2019-2025 | Shingrix, Arexvy, Bexsero |
| Amgen INC. | $191.59 | 2019-2025 | Evenity, Prolia |
| Dexcom, INC. | $175.18 | 2024-2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $170.85 | 2019-2024 | |
| Exact Sciences Corporation | $156.57 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $95.34 | 2019-2020 | |
| Medtronic, INC. | $66.61 | 2023-2025 | Intellis Adaptivestim |
| Astrazeneca Pharmaceuticals Lp | $46.48 | 2019-2020 | |
| Abbvie INC. | $40.65 | 2022 | |
| Lilly USA, LLC | $22.73 | 2019 | |
| Corcept Therapeutics | $20.37 | 2025 | Korlym |
| Inspire Medical Systems, INC. | $14.36 | 2025 | Inspire |
| Amarin Pharma, INC. | $13.85 | 2019 | |
| Shire North American Group INC | $13.81 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $12.53 | 2019 | |
| Merck Sharp & Dohme LLC | $11.51 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marina Behrad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.